Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-TT long-term persistence and 5-year booster study in adolescents and young adults
2012-002718-38Phase 2
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine and meningococcal A conjugate vaccine in meningococcal disease and meningococcal meningitis (5 arms), sponsored by GSK.
02
Drugs
meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccinemeningococcal A conjugate vaccine
03
Conditions
meningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on 2012-002718-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002718-38.